These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22193627)

  • 1. Targeting 14-3-3zeta in cancer therapy.
    Yang X; Cao W; Zhang L; Zhang W; Zhang X; Lin H
    Cancer Gene Ther; 2012 Mar; 19(3):153-9. PubMed ID: 22193627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased 14-3-3ζ expression in the multidrug-resistant leukemia cell line HL-60/VCR as compared to the parental line mediates cell growth and apoptosis in part through modification of gene expression.
    Liang R; Chen XQ; Bai QX; Wang Z; Zhang T; Yang L; Dong BX; Gao GX; Gu HT; Zhu HF
    Acta Haematol; 2014; 132(2):177-86. PubMed ID: 24603438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of 14-3-3ζ over-expression in hepatocellular carcinoma inhibits tumor growth and enhances chemosensitivity to cis-diammined dichloridoplatium.
    Choi JE; Hur W; Jung CK; Piao LS; Lyoo K; Hong SW; Kim SW; Yoon HY; Yoon SK
    Cancer Lett; 2011 Apr; 303(2):99-107. PubMed ID: 21334806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 14-3-3 zeta as novel molecular target for cancer therapy.
    Matta A; Siu KW; Ralhan R
    Expert Opin Ther Targets; 2012 May; 16(5):515-23. PubMed ID: 22512284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Over-expression of miR-451a can enhance the sensitivity of breast cancer cells to tamoxifen by regulating 14-3-3ζ, estrogen receptor α, and autophagy.
    Liu ZR; Song Y; Wan LH; Zhang YY; Zhou LM
    Life Sci; 2016 Mar; 149():104-13. PubMed ID: 26896688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 14-3-3ζ targeting induced senescence in Hep-2 laryngeal cancer cell through deneddylation of Cullin1 in the Skp1-Cullin-F-box protein complex.
    Seo SB; Baek JY; Lim JH; Jin X; Lee MY; Lee JH
    Cell Prolif; 2019 Sep; 52(5):e12654. PubMed ID: 31222857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 14-3-3ζ as a prognostic marker and therapeutic target for cancer.
    Neal CL; Yu D
    Expert Opin Ther Targets; 2010 Dec; 14(12):1343-54. PubMed ID: 21058923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of 14-3-3ζ expression in intrahepatic cholangiocarcinoma and its clinical implications.
    Zhang C; Liu LX; Dong ZR; Shi GM; Cai JB; Zhang PF; Ke AW; Yu JX; Zhou J; Fan J
    Tumour Biol; 2015 Mar; 36(3):1781-9. PubMed ID: 25391422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of 14-3-3zeta suppresses anchorage-independent growth of lung cancer cells through anoikis activation.
    Li Z; Zhao J; Du Y; Park HR; Sun SY; Bernal-Mizrachi L; Aitken A; Khuri FR; Fu H
    Proc Natl Acad Sci U S A; 2008 Jan; 105(1):162-7. PubMed ID: 18162532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Over-expression of 14-3-3zeta is an early event in oral cancer.
    Matta A; Bahadur S; Duggal R; Gupta SD; Ralhan R
    BMC Cancer; 2007 Sep; 7():169. PubMed ID: 17764575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BIS targeting induces cellular senescence through the regulation of 14-3-3 zeta/STAT3/SKP2/p27 in glioblastoma cells.
    Lee JJ; Lee JS; Cui MN; Yun HH; Kim HY; Lee SH; Lee JH
    Cell Death Dis; 2014 Nov; 5(11):e1537. PubMed ID: 25412315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New developments on targeted cancer therapy: Multi-faceted issues in targeted cancer therapy.
    Bao J; Qiao L
    Cancer Lett; 2017 Feb; 387():1-2. PubMed ID: 28038727
    [No Abstract]   [Full Text] [Related]  

  • 13. Up-regulation of 14-3-3zeta in lung cancer and its implication as prognostic and therapeutic target.
    Fan T; Li R; Todd NW; Qiu Q; Fang HB; Wang H; Shen J; Zhao RY; Caraway NP; Katz RL; Stass SA; Jiang F
    Cancer Res; 2007 Aug; 67(16):7901-6. PubMed ID: 17699796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 14-3-3ζ, a novel androgen-responsive gene, is upregulated in prostate cancer and promotes prostate cancer cell proliferation and survival.
    Murata T; Takayama K; Urano T; Fujimura T; Ashikari D; Obinata D; Horie-Inoue K; Takahashi S; Ouchi Y; Homma Y; Inoue S
    Clin Cancer Res; 2012 Oct; 18(20):5617-27. PubMed ID: 22904106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 14-3-3ζ up-regulates hypoxia-inducible factor-1α in hepatocellular carcinoma via activation of PI3K/Akt/NF-кB signal transduction pathway.
    Tang Y; Lv P; Sun Z; Han L; Luo B; Zhou W
    Int J Clin Exp Pathol; 2015; 8(12):15845-53. PubMed ID: 26884855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of MUC1 by its novel activator 14-3-3ζ promotes tumor invasion and indicates poor prognosis in lung adenocarcinoma.
    Xue M; Tao W
    Oncol Rep; 2017 Nov; 38(5):2637-2646. PubMed ID: 28901525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttranscriptional regulation of 14-3-3ζ by RNA-binding protein HuR modulating intestinal epithelial restitution after wounding.
    Hansraj NZ; Xiao L; Wu J; Chen G; Turner DJ; Wang JY; Rao JN
    Physiol Rep; 2016 Jul; 4(13):. PubMed ID: 27401462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta.
    Tsukamoto Y; Nakada C; Noguchi T; Tanigawa M; Nguyen LT; Uchida T; Hijiya N; Matsuura K; Fujioka T; Seto M; Moriyama M
    Cancer Res; 2010 Mar; 70(6):2339-49. PubMed ID: 20215506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Akt, 14-3-3ζ, and vimentin mediate a drug-resistant invasive phenotype in diffuse large B-cell lymphoma.
    Maxwell SA; Cherry EM; Bayless KJ
    Leuk Lymphoma; 2011 May; 52(5):849-64. PubMed ID: 21323512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer gene therapy targeting cellular apoptosis machinery.
    Jia LT; Chen SY; Yang AG
    Cancer Treat Rev; 2012 Nov; 38(7):868-76. PubMed ID: 22800735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.